These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37809745)

  • 1. DRESS syndrome - A dermatological emergency - Sulfasalazine-related acute drug reaction case report.
    Kanabaj K; Jenerowicz D; Jankowska L; Żaba Z
    Heliyon; 2023 Sep; 9(9):e20021. PubMed ID: 37809745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Sulfasalazine-induced hypersensitivity.
    Kuchinskaya EM; Chikova IA; Kostik MM
    Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
    Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
    BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N; Abe R; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S; Iriki H; Asahina Y; Furuichi Y; Funakoshi T; Ichikawa M; Mikami Y; Okita H; Sakiyama T; Inazumi T; Amagai M; Takahashi H
    J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) with concomitant acute chikungunya virus infection: possible role of new viral trigger.
    Sil A; Bhattacharjee MS; Chandra A; Pramanik JD
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34642219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DRESS syndrome as a result of sulfasalazine use].
    van der Mark SC; Segers D; Bakker RC; van Wijngaarden P
    Ned Tijdschr Geneeskd; 2010; 154(18):A2161. PubMed ID: 23134745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
    Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.
    Ogawa K; Mitsui Y; Miyamoto S; Nakamura-Nishimura Y; Nakanishi Y; Azukizawa H; Asada H
    J Cutan Pathol; 2019 May; 46(5):363-367. PubMed ID: 30666704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases].
    Queyrel V; Catteau B; Michon-Pasturel U; Fauchais AL; Delcey V; Launay D; Legout L; Hachulla E; Hatron PY; Devulder B
    Rev Med Interne; 2001 Jun; 22(6):582-6. PubMed ID: 11433569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine-induced DRESS.
    Teo L; Tan E
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
    J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.